Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (31-40 of 681) with videos related to

Pageof 69
Sort By:
Anaesthesia, Critical Care & Pain Medicine|January 4, 2020
The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically illRyan L Crass, Paul Williams, Jason A Roberts
Intensive Care Medicine|September 23, 2024
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerationsGreg Barton, Claire M Rickard, Jason A Roberts
Intensive Care Medicine|September 4, 2015
Understanding PK/PDJason A Roberts, Fabio Silvio Taccone, Jeffrey Lipman
JAMA|December 16, 2024
Continuous vs Intermittent β-Lactam Antibiotic Infusions for Sepsis-ReplyJoel M Dulhunty, Jason A Roberts, Jeffrey Lipman, et al.
Pharmacotherapy|April 19, 2025
Correction of posaconazole concentrations for hypoalbuminemiaDavid E Nix, Fekade Sime, Jason A Roberts
Current Opinion in Infectious Diseases|February 26, 2013
How should we dose antibiotics for pneumonia in the ICU?Andrew A Udy, Jason A Roberts, Jeffrey Lipman
Critical Care (London, England)|June 7, 2016
We need to optimize piperacillin-tazobactam dosing in critically ill patients-but how?Menino Osbert Cotta, Jason A Roberts, Jeffrey Lipman
Critical Care Medicine|May 2, 2008
Continuous infusion of beta-lactams in the intensive care unit--best way to hit the target?Jason A Roberts, Jennifer D Paratz, Jeffrey Lipman
Seminars in Respiratory and Critical Care Medicine|October 5, 2019
Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care UnitPaul Williams, Menino Osbert Cotta, Jason A Roberts
Intensive Care Medicine|April 8, 2017
What's new in pharmacokinetics of antimicrobials in AKI and RRT?Jason A Roberts, Jean-Yves Lefrant, Jeffrey Lipman
Pageof 69

Showing results (31-40 of 681) with videos related to

Sort By:
Pageof 69
Anaesthesia, Critical Care & Pain Medicine|January 4, 2020
The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically illRyan L Crass, Paul Williams, Jason A Roberts
Intensive Care Medicine|September 23, 2024
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerationsGreg Barton, Claire M Rickard, Jason A Roberts
Intensive Care Medicine|September 4, 2015
Understanding PK/PDJason A Roberts, Fabio Silvio Taccone, Jeffrey Lipman
JAMA|December 16, 2024
Continuous vs Intermittent β-Lactam Antibiotic Infusions for Sepsis-ReplyJoel M Dulhunty, Jason A Roberts, Jeffrey Lipman, et al.
Pharmacotherapy|April 19, 2025
Correction of posaconazole concentrations for hypoalbuminemiaDavid E Nix, Fekade Sime, Jason A Roberts
Current Opinion in Infectious Diseases|February 26, 2013
How should we dose antibiotics for pneumonia in the ICU?Andrew A Udy, Jason A Roberts, Jeffrey Lipman
Critical Care (London, England)|June 7, 2016
We need to optimize piperacillin-tazobactam dosing in critically ill patients-but how?Menino Osbert Cotta, Jason A Roberts, Jeffrey Lipman
Critical Care Medicine|May 2, 2008
Continuous infusion of beta-lactams in the intensive care unit--best way to hit the target?Jason A Roberts, Jennifer D Paratz, Jeffrey Lipman
Seminars in Respiratory and Critical Care Medicine|October 5, 2019
Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care UnitPaul Williams, Menino Osbert Cotta, Jason A Roberts
Intensive Care Medicine|April 8, 2017
What's new in pharmacokinetics of antimicrobials in AKI and RRT?Jason A Roberts, Jean-Yves Lefrant, Jeffrey Lipman
Pageof 69